HIGHBuilt-inProduct / Revenue mix
91%
Canadian adult-use cannabis
“10-K Item 1: 'Revenue from Canadian adult-use cannabis | | | 224,048 | | | | 91 | %'”
TLRY · Concentration risk · 10-K extracted
Tilray Brands (TLRY) concentration risks
Updated
The most significant concentration Tilray Brands discloses is Canadian adult-use cannabis at 91%, classified HIGH by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Source: Tilray Brands’s SEC Form 10-K filed — view the filing on SEC EDGAR ↗
At a glance
Disclosed-size breakdown · 2 disclosed concentrations
HIGH1
MEDIUM1
LOW0
Disclosed concentrations
Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).
MEDIUMBuilt-inProduct / Revenue mix
33%
Distribution business
“10-K Item 1: 'Distribution business | | | 271,228 | | | | 33 | %'”
TrendMatrix Research · concentration synthesis
What these concentrations mean together
updated 2026-08-09Tilray's revenue mix is dominated by two segments with materially different shares. Canadian adult-use cannabis revenue represents 91% of the relevant base, a high-share structural exposure that signals how central this single category is to that portion of the business. The Distribution business contributed 33% — a medium-share structural exposure that is meaningful but far smaller in relative terms. Both are structural rather than counterparty-specific: no single customer or supplier is named as driving either figure, and the risk instead runs through category and channel mix — regulatory shifts in Canadian adult-use cannabis policy or pricing, or changes in the distribution channel's economics, would move results more than any single relationship failing. Because the two figures come from different lines within the filing's revenue breakdown, they should not be read as components of one combined total, but each on its own describes a meaningfully concentrated line of business. The higher relative share tied to Canadian adult-use cannabis makes that category the more consequential single driver of the two, with the distribution business a secondary but still non-trivial structural concentration.
For the engine’s reasoning on TLRY’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.
Industry peers · Drug Manufacturers - Specialty & Generic
Peer concentration profile
| Symbol | Name | HIGH | MEDIUM | LOW | Total |
|---|---|---|---|---|---|
| ANIP | ANI Pharmaceuticals, Inc. | 2 | 1 | 0 | 3 |
| AMLX | Amylyx Pharmaceuticals, Inc. | 2 | 0 | 0 | 2 |
| AMPH | Amphastar Pharmaceuticals, Inc. | 1 | 2 | 1 | 4 |
| AMRX | Amneal Pharmaceuticals, Inc. | 1 | 1 | 0 | 2 |
| TLRY● | Tilray Brands, Inc. | 1 | 1 | 0 | 2 |
| ALKS | Alkermes plc | 0 | 1 | 1 | 2 |
Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.